Phase II trial of bisantrene in non-small cell lung cancer

Thomas P. Miller, Frederick R. Ahmann, Cindy Mackel, Bernard R. Greenberg, David S. Alberts

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II trial of bisantrene in non-small cell lung cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science